Metabolic reprogramming is critical to microglial activation in Huntington’s disease
Authors:
Open Access
- 26 March 2026
- journal article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 11 (10)
Abstract
Huntington’s disease (HD) is a fatal neurodegenerative disease caused by an expanded polyglutamine (CAG) repeat in the N-terminal of the huntingtin protein ( HTT ). Microglial activation and elevated proinflammatory cytokines are observed in HD brains, but the mechanisms regulating neuroinflammation and microglial activation are poorly understood. Metformin-mediated neuroprotection has been demonstrated in experimental models of neurodegeneration, including HD. We found that metformin inhibits mitochondrial DNA (mtDNA) release and subsequent neuroinflammation in the cortex and striatum of a mouse model of HD. Moreover, elevated proinflammatory cytokines and microglial activation are inhibited by metformin in HD transgenic mouse brains. Metformin reduced pathological microglial clusters and shifted toward a quiescent, homeostatic phenotype. Metformin improved aberrant immunometabolism in HD mouse brains and primary microglia. Mechanistically, we found that metformin regulates mitochondrial fission, reprograms deregulated metabolism in HD microglia, and controls microglial activation and inflammation in HD transgenic mice.Keywords
Funding Information
- NIH (R01NS100743)
- National Institute of Neurological Disorders and Stroke (R01NS100743)
This publication has 83 references indexed in Scilit:
- Metformin Protects Cells from Mutant Huntingtin Toxicity Through Activation of AMPK and Modulation of Mitochondrial DynamicsNeuroMolecular Medicine, 2016
- Therapeutic Use of Metformin in Prediabetes and Diabetes PreventionDrugs, 2015
- Acetyl-CoA and the regulation of metabolism: mechanisms and consequencesCurrent Opinion in Cell Biology, 2015
- Differential Roles of M1 and M2 Microglia in Neurodegenerative DiseasesMolecular Neurobiology, 2015
- Metformin: From Mechanisms of Action to TherapiesCell Metabolism, 2014
- Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseasesBrain Research Bulletin, 2012
- Microglial activation in regions related to cognitive function predicts disease onset in Huntington's disease: A multimodal imaging studyHuman Brain Mapping, 2011
- The non-provitamin A carotenoid, lutein, inhibits NF-κB-dependent gene expression through redox-based regulation of the phosphatidylinositol 3-kinase/PTEN/Akt and NF-κB-inducing kinase pathways: Role of H2O2 in NF-κB activationFree Radical Biology and Medicine, 2008
- Imaging microglial activation in Huntington's diseaseBrain Research Bulletin, 2007
- Redox regulation of glial inflammatory response to lipopolysaccharide and interferonγJournal of Neuroscience Research, 2004